|
1
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang
C, Dou C, Xu M, Liu Q and Tu K: Long non-coding RNA CASC2
suppresses epithelial-mesenchymal transition of hepatocellular
carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer.
16:1232017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie
Y, Wang K, Jia W, Chu WM and Sun B: The long noncoding RNA lnc-EGFR
stimulates T-regulatory cells differentiation thus promoting
hepatocellular carcinoma immune evasion. Nat Commun. 8:151292017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu YY, Chen ZH, Peng JJ, Wu JL, Yuan YJ,
Zhai ET, Cai SR, He YL and Song W: Up-regulation of long non-coding
RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to
promote metastasis by associating with Snail1 in gastric cancer.
Sci Rep. 7:24612017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei L, Wu T, He P, Zhang JL and Wu W:
LncRNA ATB promotes the proliferation and metastasis of lung cancer
via activation of the p38 signaling pathway. Oncol Lett.
16:3907–3912. 2018.PubMed/NCBI
|
|
7
|
Yang L, Xie N, Huang J, Huang H, Xu S,
Wang Z and Cai J: SIK1-LNC represses the proliferative, migrative,
and invasive abilities of lung cancer cells. Onco Targets Ther.
11:4197–4206. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Chi Q and Zhao Z: Up-regulation
of long non-coding RNA SPRY4-IT1 promotes tumor cell migration and
invasion in lung adenocarcinoma. Oncotarget. 8:51058–51065.
2017.PubMed/NCBI
|
|
9
|
Wang R, Chen XF and Shu YQ: Prediction of
non-small cell lung cancer metastasis-associated microRNAs using
bioinformatics. Am J Cancer Res. 5:32–51. 2014.PubMed/NCBI
|
|
10
|
Nymark P, Guled M, Borze I, Faisal A,
Lahti L, Salmenkivi K, Kettunen E, Anttila S and Knuutila S:
Integrative analysis of microRNA, mRNA and aCGH data reveals
asbestos- and histology-related changes in lung cancer. Genes
Chromosomes Cancer. 50:585–597. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen T, Gao F, Feng S, Yang T and Chen M:
MicroRNA-370 inhibits the progression of non-small cell lung cancer
by downregulating oncogene TRAF4. Oncol Rep. 34:461–468. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Z, Lv B, Zhang L, Zhao N and Lv Y:
miR-202 functions as a tumor suppressor in non-small cell lung
cancer by targeting STAT3. Mol Med Rep. 16:2281–2289. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang J, Huang J, Wang XR and Quan YH:
MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer
cells through targeting cyclin D1. Eur Rev Med Pharmacol Sci.
20:2278–2284. 2016.PubMed/NCBI
|
|
14
|
Liu X, Huang YG, Jin CG, Zhou YC, Chen XQ,
Li J, Chen Y, Li M, Yao Q, Li K, et al: MicroRNA-370 inhibits the
growth and metastasis of lung cancer by down-regulating epidermal
growth factor receptor expression. Oncotarget. 8:88139–88151.
2017.PubMed/NCBI
|
|
15
|
Yong-Hao Y, Xian-Guo W, Ming X and
Jin-Ping Z: Expression and clinical significance of miR-139-5p in
non-small cell lung cancer. J Int Med Res. 47:867–874. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th edition of the AJCC TNM
staging system for gastric cancer using the National Cancer
Database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Varnholt H, Drebber U, Schulze F,
Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen C, Zhang Z, Li J and Sun Y: SNHG8 is
identified as a key regulator in non-small-cell lung cancer
progression sponging to miR-542-3p by targeting CCND1/CDK6. Onco
Targets Ther. 11:6081–6090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu F, Shangli Z and Hu Z: CAV2 promotes
the growth of renal cell carcinoma through the EGFR/PI3K/Akt
pathway. Onco Targets Ther. 11:6209–6216. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T
and Song Y: Downregulation of GSDMD attenuates tumor proliferation
via the intrinsic mitochondrial apoptotic pathway and inhibition of
EGFR/Akt signaling and predicts a good prognosis in non-small cell
lung cancer. Oncol Rep. 40:1971–1984. 2018.PubMed/NCBI
|
|
21
|
Zhang L, Xu J, Yang G, Li H and Guo X:
miR-202 inhibits cell proliferation, migration, and invasion by
targeting epidermal growth factor receptor in human bladder cancer.
Oncol Res. 26:949–957. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ning T, Zhang H, Wang X, Li S, Zhang L,
Deng T, Zhou L, Liu R, Wang X, Bai M, et al: miR-370 regulates cell
proliferation and migration by targeting EGFR in gastric cancer.
Oncol Rep. 38:384–392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zou Y, Zhang B, Mao Y, Zhang H and Hong W:
Long non-coding RNA OECC promotes cell proliferation and metastasis
through the PI3K/Akt/mTOR signaling pathway in human lung cancer.
Oncol Lett. 18:3017–3024. 2019.PubMed/NCBI
|
|
24
|
He Y, Hu H, Wang Y, Yuan H, Lu Z, Wu P,
Liu D, Tian L, Yin J, Jiang K and Miao Y: ALKBH5 inhibits
pancreatic cancer motility by decreasing long non-coding RNA
KCNK15-AS1 methylation. Cell Physiol Biochem. 48:838–846. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo N, Zhao Y, Zhang W, Li S, Li S and Yu
J: MicroRNA-133a downregulated EGFR expression in human non-small
cell lung cancer cells via AKT/ERK signaling. Oncol Lett.
16:6045–6050. 2018.PubMed/NCBI
|
|
26
|
Li B, Ding CM, Li YX, Peng JC, Geng N and
Qin WW: MicroRNA145 inhibits migration and induces apoptosis in
human non-small cell lung cancer cells through regulation of the
EGFR/PI3K/AKT signaling pathway. Oncol Rep. 40:2944–2954.
2018.PubMed/NCBI
|
|
27
|
Zhang S, Cai J, Xie W, Luo H and Yang F:
miR-202 suppresses prostate cancer growth and metastasis by
targeting PIK3CA. Exp Ther Med. 16:1499–1504. 2018.PubMed/NCBI
|
|
28
|
Gao S, Cao C, Dai Q, Chen J and Tu J:
miR-202 acts as a potential tumor suppressor in breast cancer.
Oncol Lett. 16:1155–1162. 2018.PubMed/NCBI
|
|
29
|
Li C, Ma D, Yang J, Lin X and Chen B:
miR-202-5p inhibits the migration and invasion of osteosarcoma
cells by targeting ROCK1. Oncol Lett. 16:829–834. 2018.PubMed/NCBI
|
|
30
|
Sun W, Ping W, Tian Y, Zou W, Liu J and Zu
Y: miR-202 enhances the anti-tumor effect of cisplatin on non-small
cell lung cancer by targeting the Ras/MAPK pathway. Cell Physiol
Biochem. 51:2160–2171. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K
and Chen Z: Effects of miR-1236-3p and miR-370-5p on activation of
p21 in various tumors and its inhibition on the growth of lung
cancer cells. Tumour Biol. 39:10104283177108242017. View Article : Google Scholar : PubMed/NCBI
|
